Richard Goldberg, MD
Director and Laurence S. and Jean J. DeLynn Chair of Oncology, Professor of Medicine

As director of the Cancer Institute, Dr. Goldberg oversees the clinical, research, and teaching missions of the institution and its component organizations, which include satellite clinical and clinical research locations that are dispersed throughout West Virginia.

Considered an international leader in gastrointestinal cancer treatment and research as well as in leadership of cancer programs in academic medicine, Goldberg’s clinical interests are in management of patients with malignancies in the gastrointestinal tract, particularly colorectal and neuroendocrine cancers.

His research focuses on defining new treatments, elucidating inherited cancer susceptibility, and identification of predictive and prognostic factors in GI cancers. He helps to lead the Alliance for Clinical Trials in Oncology as the Associate Group Chair of this NCI funded organization that is a member of the National Clinical Trials Network. The Alliance conducts clinical trials and does translational research across the US and Canada. He has been principal investigator, co-PI, co-investigator and mentor on multiple research and training grants funded through the National Cancer Institute (NCI). He has published more than 320 papers in peer-reviewed journals. One of his studies involving colorectal cancer has been cited more than 1,360 times, led to more than 30 publications, and more than 40 abstracts with related presentations at international meetings.

Goldberg is a sought-after lecturer at academic centers and scientific conferences across the nation and the world. He has mentored many MD, MD/PhD, and PhD doctoral students, post-doctoral researchers and junior faculty over his 33 years as a medical oncologist in academic settings.

He is a graduate of Harvard University, earning an undergraduate degree cum laude in biology in 1975 and received his medical degree from the State University of Ney York Upstate Medical University in 1989 where he was elected to the Alpha Omega Alpha honor medical society. He was an intern and resident in internal medicine at Emory University Hospital in Atlanta, and completed a fellowship in medical oncology at the Vincent T. Lombardi Cancer Research Center in Washington, DC.

Prior to his arrival at WVU in 2017, he served as physician in chief of the both the James Cancer Hospital at The Ohio State University and, prior to that, of the North Carolina Cancer Hospital at the University of North Carolina. He was an associate director at both the OSU and the UNC Comprehensive Cancer Centers and was the division chief of hematology and oncology at UNC and acting division director of medical oncology at OSU.

Prior to that he was a consultant at the Mayo Clinic in Rochester, Minn., and associate chair of the Department of Medicine at the Geisinger Clinic in Danville, Pa.

Goldberg serves as a member of WVU Health Sciences Vice President and Executive Dean Clay Marsh’s leadership team. Nationally, he serves on several scientific advisory committees and on the scientific advisory committee for a number of pharmaceutical companies at the corporate level. He is a fellow in the American College of Physicians and the American Society of Clinical Oncology.

He is married to Lynda Goldberg MBA, MPH and has two adult children.


Richard Funnell, M.H.A., F.A.C.H.E., C.M.P.E. , Vice President of Cancer ServicesRichard Funnell, M.H.A., F.A.C.H.E., C.M.P.E.
Vice President of Cancer Services

In his role as vice president, Richard Funnell’s focus is on changing the way cancer care is delivered by focusing on the patient experience and delivering value by lowering costs and improving access through more efficient operations across the network. He plans to grow the program’s capacity to serve a larger number of patients through fostering relationships across the state.

Funnell comes to WVU Medicine from the University of Pennsylvania Health System, Penn Medicine, where he served as chief administrative officer of the cancer service line and was responsible for the strategic direction and clinical operations of the Abramson Cancer Center, a National Cancer Institute Comprehensive Cancer Center (NCI-CCC), and the Penn Cancer Network. Prior to Penn Medicine, Funnell served as senior director of business development for oncology at Spectrum Health in Grand Rapids, Michigan, and as senior administrator for medical and pediatric oncology services at Roswell Park Cancer Institute, a freestanding NCI-CCC, in Buffalo, N.Y.

He completed a Master of Science in Health Administration at the University of Missouri, followed by an administrative fellowship at the State University of New York at Stony Brook University Hospital and Medical Center.


Michael Craig, MD
Michael Craig, MD
Physician-in-Chief of Oncology, WVU Cancer Institute Clinics
Director of the Hematopoietic Malignancy and Bone Marrow Transplant Service, Alexander B. Osborn Hematopoietic
Section Chief of Hematology and Oncology
Malignancy and Transplantation Program Clinical Service
Professor of Medicine


 Dorazio
Jennifer Dorazio
Assistant Director for Administration, WVU Cancer Institute
Administrator, Hematology/Oncology, Medicine


 Hannah Hazard, MD
Hannah W. Hazard, MD, FACS
Director of Clinical Services, WVU Cancer Institute Clinics
Associate Professor, Surgery


Geraldine Jacobson, MD, MPH, MBA
Geraldine M. Jacobson, MD, MPH, MBA, FACR, FASTRO
Chair, Department of Radiation Oncology
Professor of Radiation Oncology


Kennedy-Rea
Stephenie Kennedy-Rea, EdD
Associate Director for Cancer Prevention and Control, WVU Cancer Institute Administration
Director, Cancer Prevention and Control
Associate Director of Mountaineer Health Initiative
Research Assistant Professor, Medicine


Paul Lockman Directory Photo
Paul Lockman, PhD, BSN
Associate Director for Translational Research, WVU Cancer Institute
Assistant Vice President of Experimental Therapeutics
West Virginia University Health Sciences Center
Benedum Fellow and the Douglas Glover Endowed Chair
Professor, Department of Basic Pharmaceutical Sciences, School of Pharmacy


William Petros Directory Photo
William P. Petros, PharmD
Associate Director for Anti-Cancer Drug Development, WVU Cancer Institute
Dean, School of Pharmacy
The Gates Wigner Endowed Chair & Professor of Pharmaceutical Sciences


Schnatterly
Anne Schnatterly, BSN, RN, CCRP
Director Oncology Clinical Services, Clinical Trials Research Unit